BRISTOL-MYERS SQUIBB COMPANY

Calendar Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Pharmaceuticals

Market Closed - Nyse Other stock markets 04:00:02 2026-04-10 pm EDT			5-day change	1st Jan Change
58.62 ^USD	-1.43%		-1.64%	+8.68%

Apr. 10	Bristol-Myers Squibb Poised for In-Line Q1 Amid One-Off Volatility, RBC Says	MT
Apr. 10	Replimune's drug for advanced skin cancer fails to win FDA nod again	RE

Chart calendar Bristol-Myers Squibb Company

614b308b0bb9fcbc37fe.s-YlOKQw8pYli-A3Hwq02mmEE6ikHhGkIUZfX2Wrszo.hYtRbM5ywqFqxqhlTTONlFy0R8vUM1jHTiQuDhzG0guClXIJ4Qec2B3sgw~10d35372b9424f1f5deb6c09db618c10

Upcoming events on Bristol-Myers Squibb Company

2026-04-30	Earnings presentation	08:00 am
2026-04-30	Earnings release - Q1 2026	~ 12:30 pm
2026-05-04	Annual General Meeting	Day
2026-05-05	Présentation aux Actionnaires / Analystes	10:00 am
2026-07-30	Earnings presentation	08:00 am
2026-10-29	Earnings presentation	08:00 am

Past events on Bristol-Myers Squibb Company

2026-02-05	Earnings presentation	08:00 am
2026-02-05	Earnings release - Q4 2025	~ 12:30 pm
2025-12-11	Présentation aux Actionnaires / Analystes	09:00 am
2025-10-30	Earnings presentation	08:00 am
2025-10-30	Earnings release - Q3 2025	~ 09:30 am
2025-07-31	Earnings presentation	08:00 am
2025-07-31	Earnings release - Q2 2025	~ 12:30 pm
2025-05-06	Présentation aux Actionnaires / Analystes	10:00 am
2025-05-06	Annual General Meeting	10:00 am
2025-04-24	Earnings presentation	08:00 am
2025-04-24	Earnings release - Q1 2025	~ 12:30 pm

Past dividends on Bristol-Myers Squibb Company

2026-04-02	Ex-dividend date - 0.63 USD	12:00 am
2026-01-02	Ex-dividend date - 0.63 USD	12:00 am
2025-10-03	Ex-dividend date - 0.62 USD	12:00 am
2025-07-03	Ex-dividend date - 0.62 USD	12:00 am

Annual results

Fiscal Period	December	2023	2024	2025	2026	2027	2028
Net sales Million USD	Released Forecast Spread	45 006 44 731 0.62%	48 300 47 506 1.67%	48 194 47 987 0.43%	47 163	46 105	40 858
EBITDA Million USD	Released Forecast Spread	17 498 18 255 -4.15%	5 932 5 511 7.64%	18 649 15 415 20.98%	17 841	17 708	15 336
EBIT Million USD	Released Forecast Spread	16 785 16 921 -0.8%	5 204 4 740 9.79%	14 638 14 601 0.25%	16 358	16 103	14 083
Earnings before Tax (EBT) Million USD	Released Forecast Spread	8 440 8 846 -4.59%	-8 379 -6 919 -21.1%	9 328 9 802 -4.83%	12 764	13 369	12 681
Net income Million USD	Released Forecast Spread	8 025 7 823 2.58%	-8 948 -6 289 -42.28%	7 054 7 645 -7.73%	10 255	10 128	9 575
EPS USD	Released Forecast Spread	3,86 3,73 3.53%	-4,41 -3,09 -42.5%	3,46 4,02 -13.94%	4,94	5,08	4,69
Announcement Date		02/02/24	06/02/25	05/02/26	-

Quarterly results

Fiscal Period	December	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1	2027 Q2	2027 Q3	2027 Q4
Net sales Million USD	Released Forecast Spread	12 201 11 522 5.9%	11 892 11 246 5.75%	12 342 11 564 6.73%	11 201 10 706 4.62%	12 269 11 384 7.77%	12 222 11 800 3.58%	12 502 12 282 1.79%	10 897	11 864	12 097	12 305	10 758	11 622	11 824	12 050
EBITDA Million USD	Released Forecast Spread	7 477 4 280 74.7%	7 037 3 974 77.08%	4 394 4 059 8.25%	5 189 3 830 35.48%	4 462 3 079 44.89%	5 067 4 001 26.63%	3 930 3 042 29.17%	4 237	4 841	4 757	4 580	4 706	4 894	4 884	4 709
EBIT Million USD	Released Forecast Spread	4 881 4 008 21.78%	4 445 3 806 16.8%	4 207 3 725 12.93%	4 177 3 699 12.93%	3 451 2 736 26.14%	4 056 3 777 7.38%	2 953 2 914 1.35%	3 843	4 338	4 224	4 084	3 868	4 298	4 194	4 059
Earnings before Tax (EBT) Million USD	Released Forecast Spread	1 286 1 175 9.45%	1 676 1 373 22.07%	175 1 278 -86.31%		1 773 605 193.06%	3 114 2 620 18.85%	1 470 3 314 -55.64%	2 925	3 278	3 012	2 631
Net income Million USD	Released Forecast Spread	1 680 1 110 51.33%	1 211 964 25.66%	72,0 1 756 -95.9%	2 456 2 665 -7.84%	1 310 1 350 -2.95%	2 201 2 316 -4.95%	1 087 2 075 -47.61%	2 497	2 764	2 684	2 467	2 192	2 311	2 183	2 063
EPS USD	Released Forecast Spread	0,83 0,68 21.8%	0,60 0,65 -7.93%	0,04 0,90 -95.56%	1,20 1,25 -3.79%	0,64 0,67 -3.8%	1,08 1,04 3.44%	0,53 0,98 -45.73%	1,15	1,32	1,29	1,21	1,07	1,13	1,07	1,01
Announcement Date		26/07/24	31/10/24	06/02/25	24/04/25	31/07/25	30/10/25	05/02/26	-	-	-	-	-	-	-	-

Upcoming sector events for Bristol-Myers Squibb Company

2026-04-13	SANDOZ GROUP AG	Ex-dividend date - 0.8 CHF	12:00 am
2026-04-13	HAISCO PHARMACEUTICAL GROUP CO., LTD.	Earnings release - Annual 2025	~ 03:00 am
2026-04-13	APELOA PHARMACEUTICAL CO.,LTD	Annual General Meeting	02:30 am
2026-04-12	HISAMITSU PHARMACEUTICAL CO., INC.	Earnings release - Annual 2026	Day
2026-04-13	TIBET RHODIOLA PHARMACEUTICAL HOLDING CO.	Annual General Meeting	02:30 am
2026-04-13	TEYI PHARMACEUTICAL GROUP CO.,LTD	Earnings presentation	03:00 am
2026-04-13	ASP ISOTOPES INC.	Information meeting	08:00 am
2026-04-14	JOHNSON & JOHNSON	Earnings release - Q1 2026	06:45 am
2026-04-14	JOHNSON & JOHNSON	Earnings presentation	08:30 am
2026-04-14	SIEGFRIED HOLDING AG	Annual General Meeting	04:00 am

Past sector events for Bristol-Myers Squibb Company

Today	ZHEJIANG MEDICINE CO., LTD.	Earnings release - Annual 2025	~ 03:00 am
Today	HAINAN HAIYAO CO., LTD.	Earnings release - Annual 2025	~ 03:00 am
Today	SHANGHAI NEW WORLD CO., LTD	Earnings release - Annual 2025	~ 03:00 am
2026-04-10	LIVZON PHARMACEUTICAL GROUP INC.	Earnings presentation	03:00 am
2026-04-10	BRIGHTGENE BIO-MEDICAL TECHNOLOGY CO., LTD.	Annual General Meeting	02:00 am
2026-04-10	COSMO PHARMACEUTICALS N.V.	Annual General Meeting	06:00 am
2026-04-10	ZHEJIANG YATAI PHARMACEUTICAL CO., LTD.	Extraordinary General Meeting	02:45 am
2026-04-10	JIANMIN PHARMACEUTICAL GROUP CO.,LTD.	Annual General Meeting	02:00 am
2026-04-10	ZHEJIANG HAISEN PHARMACEUTICAL CO., LTD.	Earnings presentation	03:00 am
2026-04-09	SUPRIYA LIFESCIENCE LIMITED	Extraordinary General Meeting	Day

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

Stock Market
Equities
BMY Stock
Calendar Bristol-Myers Squibb Company

Stock markets for all

100% Free Registration

100% Free Registration